Reply to Simone Sforza’s Letter to the Editor re: Mehdi Kardoust Parizi, David D’Andrea, Benjamin Pradere, et al. Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients. In press. http://dx.doi.org/10.1016/j.euo.2026.06.001
Reply to Simone Sforza’s Letter to the Editor re: Mehdi Kardoust Parizi, David D’Andrea, Benjamin Pradere, et al. Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients. In press. http://dx.doi.org/10.1016/j.euo.2026.06.001. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126002312?dgcid=rss_sd_all
Reply to Simone Sforza’s Letter to the Editor re: Mehdi Kardoust Parizi, David D’Andrea, Benjamin Pradere, et al. Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients. In press. http://dx.doi.org/10.1016/j.euo.2026.06.001. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126002312?dgcid=rss_sd_all
“Reply to Simone Sforza’s Letter to the Editor re: Mehdi Kardoust Parizi, David D’Andrea, Benjamin Pradere, et al. Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients. In press. http://dx.doi.org/10.1016/j.euo.2026.06.001.” European Urology Oncology.
@article{article45781,
title = {Reply to Simone Sforza’s Letter to the Editor re: Mehdi Kardoust Parizi, David D’Andrea, Benjamin Pradere, et al. Prognostic Factors for Recurrence and Survival After Radical Cystectomy for Non–muscle-invasive Bladder Cancer: A Multicenter Analysis of 1032 Patients. In press. http://dx.doi.org/10.1016/j.euo.2026.06.001},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126002312?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...